Hosted on MSN22h
Piper Sandler Downgrades Amphastar Pharmaceuticals (AMPH)Fintel reports that on February 4, 2025, Piper Sandler downgraded their outlook for Amphastar Pharmaceuticals (NasdaqGS:AMPH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback